Skip to main content
European Health and Digital Executive Agency (HaDEA)
Sejħa għall-offertiMagħluqin

Framework Contract for the Reservation of Capacities and a Priority Right for Manufacturing of Vaccines (EU FAB)

Dettalji

Status
Magħluqin
Referenza
HADEA/2022/CPN/0009
Data tal-pubblikazzjoni
Data tal-ftuħ
Data ta' skadenza
Programme Sector
Health
Programme
EU4Health
Tags
HealthUnionMedical researchPharmaceutical industryPublic healthPublic procurementScientific researchTendering

Deskrizzjoni

Financed by HERA’s annual work plan for 2022, the Commission, in cooperation with HaDEA, is launching EU FAB, with the objective to ensure that sufficient and agile manufacturing capacities for different vaccine types are kept operational and can be activated quickly in case of a public health emergency.

The purpose of this framework contract is to reserve the capacity and a priority right to manufacture vaccines for a minimum of 450 million doses under all lots.

Estimated total value: €160 million

Duration of the contract: 48 months

More information